, Tracking Stock Market Picks
Enter Symbol:
Celgene Corporation (CELG) [hlAlert]

up 349.87 %

Celgene Corporation (CELG) rated Buy by Merriman

Posted on: Tuesday,  Jul 28, 2009  8:25 AM ET by Merriman

Merriman rated Buy Celgene Corporation (NASDAQ: CELG) on 07/28/2009, when the stock price was $27.35. Since
then, Celgene Corporation has gained 349.87% as of 01/14/2016's recent price of $123.04.
If you would have followed this Merriman's recommendation on CELG, you would have gained 349.87% of your investment in 2361 days.

Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.

Merriman provides advanced tools for acquiring such information. These tools integrate a combination of cycles, geocosmic signatures and trend analysis patterns in assisting the serious investor in their interpretation of the various financial markets and the general economy. In today's fast paced and seemingly chaotic marketplace, you need the edge that only a broader analysis of human activity can provide.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/28/2009 8:25 AM Buy
as of 12/31/2009
1 Week down  -0.62 %
1 Month up  1.04 %
3 Months up  0.23 %
1 YTD up  2.43 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy